Merck ends COVID vaccine program, cites inferior immune responses
Reuters via Yahoo News· 21 hours agoIn early trials, both vaccines generated immune responses that were inferior to those seen in people...
Trailing the First Vaccines, Next Generation Turns to Variants
Bloomberg· 2 hours agoThe rapid rollout of vaccines from front-runners including Pfizer Inc. is forcing those trailing...
Merck Scraps Covid-19 Vaccine Programs
Barron s Online· 20 hours agoIn December, Sanofi (SNY) and GlaxoSmithKline (GSK) announced a delay in their joint Covid-19 vaccine program after results of their early trial showed...
Another GSK vaccine exec jumps ship for biotech CEO role
FierceBiotech· 5 days agoGlaxoSmithKline is losing another vaccine executive in the midst of developing a COVID-19 shot. This...
Merck Stops Developing Both Of Its COVID-19 Vaccine Candidates
NPR· 20 hours agoOthers include Moderna and Pfizer/BioNTech – both of which now have U.S.-approved vaccines – along...
How Big a Setback Is Merck’s Vaccine Flop?
Bloomberg· 15 hours agoSam Fazeli, a Bloomberg Opinion contributor who covers the pharmaceutical industry for Bloomberg Intelligence, answered questions about Merck & Co.’s...
Elderly begin to drop out of Novavax vaccine trial to get Pfizer and Moderna shots
Washington Post· 7 days agoThe subjects wanted to get out of the clinical trial Luft is helping oversee of an experimental...
GSK - Stock quote for GlaxoSmithKline PLC - MSN Money
MSN News· 5 days agoView the latest GSK stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of GlaxoSmithKline PLC.
Slow Vaccine Campaign Remains a ‘Puzzle’ to Ex-Warp Speed Chief
Bloomberg· 3 days agoThe renowned immunologist and former head of GlaxoSmithKline Plc’s vaccines division is a bit a...
It Was a Grim Morning in the Covid-19 Fight. The Market Is Looking to Johnson & Johnson for Hope.
Barron s Online· 13 hours agoFirst came the news that Merck (ticker: MRK) was giving up on the two Covid-19 vaccines it had been...